Marcus A. Urey

1.1k total citations
32 papers, 458 citations indexed

About

Marcus A. Urey is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Transplantation. According to data from OpenAlex, Marcus A. Urey has authored 32 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 15 papers in Cardiology and Cardiovascular Medicine and 9 papers in Transplantation. Recurrent topics in Marcus A. Urey's work include Transplantation: Methods and Outcomes (14 papers), Renal Transplantation Outcomes and Treatments (9 papers) and Mechanical Circulatory Support Devices (7 papers). Marcus A. Urey is often cited by papers focused on Transplantation: Methods and Outcomes (14 papers), Renal Transplantation Outcomes and Treatments (9 papers) and Mechanical Circulatory Support Devices (7 papers). Marcus A. Urey collaborates with scholars based in United States, Italy and Australia. Marcus A. Urey's co-authors include Douglas Darden, Jonathan C. Hsu, Douglas Stoller, Benjamin D. Levine, Satyam Sarma, Eric Adler, Beverley Adams‐Huet, Justin S. Lawley, Erin J. Howden and William K. Cornwell and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Marcus A. Urey

24 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcus A. Urey United States 7 273 119 66 63 60 32 458
Frank G. Aguilar United States 10 539 2.0× 27 0.2× 14 0.2× 42 0.7× 73 1.2× 15 663
Nikolaos Stalikas Greece 12 221 0.8× 55 0.5× 7 0.1× 43 0.7× 61 1.0× 36 387
George Koulaouzidis United Kingdom 9 159 0.6× 29 0.2× 4 0.1× 36 0.6× 50 0.8× 35 281
Alessia Urbinati United Kingdom 10 338 1.2× 21 0.2× 22 0.3× 22 0.3× 97 1.6× 19 431
Florian A. Wenzl Switzerland 12 183 0.7× 66 0.6× 6 0.1× 44 0.7× 119 2.0× 38 394
Peter Farjo United States 7 200 0.7× 15 0.1× 9 0.1× 33 0.5× 47 0.8× 22 331
Victoria Hughes United Kingdom 12 94 0.3× 59 0.5× 61 0.9× 121 1.9× 122 2.0× 22 694
Tetsu Tanaka Germany 14 422 1.5× 44 0.4× 4 0.1× 169 2.7× 107 1.8× 61 535
Grant Duffy United States 8 189 0.7× 20 0.2× 4 0.1× 28 0.4× 40 0.7× 14 331

Countries citing papers authored by Marcus A. Urey

Since Specialization
Citations

This map shows the geographic impact of Marcus A. Urey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus A. Urey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus A. Urey more than expected).

Fields of papers citing papers by Marcus A. Urey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcus A. Urey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus A. Urey. The network helps show where Marcus A. Urey may publish in the future.

Co-authorship network of co-authors of Marcus A. Urey

This figure shows the co-authorship network connecting the top 25 collaborators of Marcus A. Urey. A scholar is included among the top collaborators of Marcus A. Urey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcus A. Urey. Marcus A. Urey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kim, Paul, Jeffrey J. Teuteberg, Kiran K. Khush, et al.. (2025). Donor-Derived Cell-Free DNA in Antibody-Mediated Rejection. JACC Heart Failure. 14(1). 102716–102716. 1 indexed citations
3.
Tada, Yuko, Florin Vaida, Nicholas Wettersten, et al.. (2025). Surveillance donor-specific antibody and pathologic antibody-mediated rejection testing in heart transplant patients in the contemporary era. The Journal of Heart and Lung Transplantation. 44(7). 1036–1049. 1 indexed citations
4.
Tedford, Ryan J., Brian A. Houston, JoAnn Lindenfeld, et al.. (2025). Left Atrial to Coronary Sinus Shunting in More Advanced Heart Failure with Preserved Ejection Fraction. ESC Heart Failure. 12(4). 2583–2590.
5.
Bui, Quan M., Alessia Argirò, Sarah S. Murray, et al.. (2025). Cardiomyopathy genetic testing: insights into demographics, counseling, and cascade screening. Future Cardiology. 21(6). 359–364.
6.
7.
Ho, Gordon, Frederick T. Han, Kurt S. Hoffmayer, et al.. (2024). Catheter ablation vs advanced therapy for patients with severe heart failure and ventricular electrical storm. Heart Rhythm. 22(3). 693–700. 1 indexed citations
8.
Bui, Quan M., Alessia Argirò, José B. Cruz Rodríguez, et al.. (2024). Donor-derived cell-free DNA, gene expression profile, and acute rejection in donation after circulatory death (DCD) heart transplant recipients. SHILAP Revista de lepidopterología. 5. 100099–100099.
9.
Urey, Marcus A., et al.. (2024). Adults with Congenital Heart Disease and Transplant. Heart Failure Clinics. 20(2). 167–174. 1 indexed citations
10.
Bui, Quan M., Eric Adler, Lawrence Ang, et al.. (2024). Cardiac allograft vasculopathy outcomes among donation after circulatory death heart transplant recipients. SHILAP Revista de lepidopterología. 4. 100065–100065. 2 indexed citations
11.
Argirò, Alessia, Sarah S. Murray, Grace Lin, et al.. (2024). Genetic Testing Practices and Pathological Assessments in Patients With End-stage Heart Failure Undergoing Heart Transplantation and Left Ventricular Assist Device Use. Journal of Cardiac Failure. 31(7). 1039–1047. 1 indexed citations
12.
Vaida, Florin, Nicholas Wettersten, Yuko Tada, et al.. (2023). Incidence of Acute Rejection Compared With Endomyocardial Biopsy Complications for Heart Transplant Patients in the Contemporary Era. Transplantation. 108(5). 1220–1227. 5 indexed citations
13.
Brubaker, Aleah L., Marcus A. Urey, Justin Parekh, et al.. (2023). Heart-liver-kidney transplantation for AL amyloidosis using normothermic recovery and storage from a donor following circulatory death: Short-term outcome in a first-in-world experience. American Journal of Transplantation. 23(2). 291–293. 6 indexed citations
14.
King, Kevin R., et al.. (2022). Biopsy-Proven Giant Cell Myocarditis Following the COVID-19 Vaccine. Circulation Heart Failure. 15(4). e009321–e009321. 9 indexed citations
15.
Alshawabkeh, Laith, Alexander R. Opotowsky, Tajinder P. Singh, et al.. (2022). The role of sensitization in post-transplant outcomes in adults with congenital heart disease sensitization in adults with congenital heart disease. SHILAP Revista de lepidopterología. 8. 100384–100384. 1 indexed citations
16.
Duran, Jason M., Douglas Darden, Marcus A. Urey, et al.. (2021). Association between implantable cardioverter-defibrillator and survival in patients awaiting heart transplantation: A meta-analysis and systematic review. Heart Rhythm O2. 2(6). 710–718. 2 indexed citations
17.
Hsu, Jonathan C., Douglas Darden, Ulrika Birgersdotter‐Green, et al.. (2020). Effect of closed loop stimulation versus accelerometer on outcomes with cardiac resynchronization therapy: the CLASS trial. Journal of Interventional Cardiac Electrophysiology. 61(3). 479–485. 2 indexed citations
18.
Adler, Eric, Adriaan A. Voors, Liviu Klein, et al.. (2019). Improving Risk Prediction in Heart Failure Using Machine Learning. European Journal of Heart Failure. 22(1). 139–147. 146 indexed citations
19.
Howden, Erin J., Satyam Sarma, Justin S. Lawley, et al.. (2018). Reversing the Cardiac Effects of Sedentary Aging in Middle Age—A Randomized Controlled Trial. Circulation. 137(15). 1549–1560. 128 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frank G. Aguilar Breakdown of academic impact, for papers by Nikolaos Stalikas Breakdown of academic impact, for papers by George Koulaouzidis Breakdown of academic impact, for papers by Alessia Urbinati Breakdown of academic impact, for papers by Florian A. Wenzl Breakdown of academic impact, for papers by Peter Farjo Breakdown of academic impact, for papers by Victoria Hughes Breakdown of academic impact, for papers by Tetsu Tanaka Breakdown of academic impact, for papers by Grant Duffy
Rankless by CCL
2026